A total of 99 patients with head and neck cancer who were to undergo surgery were randomized in a prospective comparative study of sulbactam-ampicillin (1:2 ratio; four doses of 3 g of ampicillin and 1.5 g of sulbactam intravenously [i.v.] Wound infections occurred in 14 (33%) sulbactamampicillin-treated patients and 9 (21%) clindamycin-amikacin-treated patients (P = 0.19; not significant). The rates of bacteremia were 2 and 4%, respectively. The rates of bronchopneumonia were 14.3 and 23.2%, respectively (P was not significant). Most infections were polymicrobial, but strict anaerobes were recovered only from patients who received sulbactam-ampicillin. Antimicrobial treatment was required within 20 days after surgery for 42% of the sulbactam-ampicillin-treated patients and 44% of the clindamycin-amikacintreated patients. By comparison with previous studies, we observed a decreased efficacy of antimicrobial prophylaxis in patients with head and neck cancer undergoing surgery because of the increased proportion of patients who were at very high risk for infection (extensive excision and plastic reconstruction in patients with recurrent stage III and IV cancers) and because of the longer durations of surgery.
It has been proven and widely accepted that patients with head and neck cancer undergoing surgery (clean contaminated procedures) benefit from preoperative antibiotic prophylaxis once the skin and oropharyngeal cavities are opened (5, 17, 18, 27, 30) . Simple laryngectomy has been associated with a very low risk of infection (<4%) (5, 20) . Placebo-controlled studies are considered unethical in patients undergoing surgery for head and neck cancer (excluding simple laryngectomy), and any new regimen should be compared with an effective regimen, which has been clindamycin plus an aminoglycoside (netilmicin or amikacin), as determined from studies previously performed in our center (11, 27) . The combination of a P-lactam antibiotic with a 1-lactamase inhibitor has a spectrum of activity very similar to that of the clindamycin-amikacin combination, including strict anaerobes. However, in recent studies, we have documented that a significant number of failures were due to methicillin-resistant staphylococci (11, 27) . The in vitro activity of the combination ampicillin-sulbactam against methicillin-resistant staphylococci is high (21, 23, 34) , and the combination of amoxicillin-clavulanic acid was found to be effective in a rat model of endocarditis (7) . On the other hand, the combination of clindamycin-amikacin is consid-ered to be ineffective against those bacteria, since methicillin-resistant staphylococci are frequently resistant to clindamycin and should probably be considered to be resistant to amikacin as well.
As far as the choice of the ,-lactamase inhibitor is concerned, sulbactam has two advantages over clavulanic acid; it is more potent (up to 100-fold) in inhibiting the class I enzymes (chromosomal cephalosporinases) present in opportunistic members of the family Enterobacteriaceae and nonfermenting, gram-negative rods (14) , and it is not an inducer of the class I enzymes, although the clinical role of induction remains highly controversial (24) . Various combinations that include sulbactam have been found to be very effective in ex vivo studies in human volunteers when the measures of bactericidal titers in serum and killing rates are used (32) (33) (34) .
The purpose of the present study was to compare the effectiveness of the ampicillin-sulbactam combination with that of our reference regimen (clindamycin-amikacin).
MATERUILS AND METHODS
The study was prospective and randomized. The study was done according to the Declaration of Helsinki (Venice Revision, 1983) . The protocol has been reviewed and approved by the Ethical Committee of the Institut Jules Bordet. All patients gave informed consent. Randomization was performed by using sealed envelopes that assigned the patient to one of the two test regimens.
Inclusion criteria were stage II, III, and IV head and neck cancer selected for extensive surgery (with or without radical neck dissection and flap reconstruction). Patients with simple laryngectomy, partial glossectomy, and pharyngoplasty were not included. Patients with intolerance to 1-lactam antibiotics, lincosamides, macrolides, and aminoglycosides were not included. Group 1 patients received the combination of sulbactam-ampicillin (1:2) as 3 g of ampicillin and 1.5 g of sulbactam, intravenously every 6 h; the drugs were infused over 30 min, and each patient received four doses. Group 2 patients received clindamycin (600 mg every 6 h [for four doses] and amikacin (500 mg every 12 h [for two doses] infused over 30 min). The first dose was given at the induction of anesthesia; the last dose was given 24 h postinduction of anesthesia.
From July 1987 to January 1990, 99 patients with histologically proven head and neck cancer who were hospitalized at the Institut Jules Bordet were included in the study. Definitions and procedures were similar to those described previously (11, 28) .
The patients were examined daily by one of the physicians of the infectious diseases clinic (M.A., P.V., M.P.). The final interpretation of each case report form was reviewed by M.A. Any discrepancy was discussed by the two other physicians. The decision to administer antibiotic therapy after surgery (hence, the decision of a failure of prophylaxis) was taken by one of the physicians of the infectious diseases clinic (M.A., P.V., M.P., F.M.). Those During evaluation of antimicrobial prophylaxis, septicemia, wound or pulmonary infection, and/or the need to administer systemic antibiotics within 20 days of surgery were considered to indicate the failure of prophylaxis.
Wound infection was defined as a clinically documented infection localized at the surgical site and presenting with a purulent discharge with a severe inflammatory reaction (>5 cm of erythema and induration). A mucocutaneous fistula also reflected a wound infection. This definition corresponds to grades 4 and 5 of Johnson and colleagues (5, (16) (17) (18) (19) (20) . All wound specimens (swabs or syringe aspirates) were processed microbiologically both for aerobic and anaerobic culture, in addition to analysis of volatile fatty acids by gas-liquid chromatography to indicate the presence of strict anaerobes (26) . Pulmonary infection was characterized by the production of purulent sputum, radiological signs of bronchopneumonia, and/or rales. The minimal criteria for the diagnosis of pneumonia were a new infiltrate on the chest X ray and purulent sputum in a febrile (>38°C) patient. Microorganisms isolated from the patients were considered significant pathogens if they were present on Gram staining and were isolated in pure culture or as the predominant microorganisms. A delay to the time of infection corresponded to the time between surgery and the first signs or symptoms of infection at each relevant site.
In vitro susceptibility testing of aerobes and facultative bacteria was done by the disk diffusion method described by the National Committee for Clinical Laboratory Standards (25a). Anaerobes were tested by disk diffusion on blood agar by using the Rosco agar disk diffusion method (7a The strains used for quality control were Bacteroidesffragilis ATCC 25285 and Bacteroides thetaiotaomicron ATCC 29741; both strains are susceptible to ampicillin-sulbactam, B. fragilis is susceptible to clindamycin, and B. thetaiotaomicron is resistant to clindamycin. This method is similar to the method of Horn et al. (13) , which has been validated by Barry et al. (2) . The validity of a 1:1 ratio for the ampicillin-sulbactam test disk has recently been discussed extensively by Jenkins (15) .
Inclusion of 50 patients in each arm of the study had a power of 0.79 to detect a difference in cure rate of 0.20 (from 0.65 to 0.85) with an alpha error of 0.1 (single tailed).
All statistical tests were done with Macintosh SE/30 hardware and Statview 512+ software (Version 1.1, 1986; Abacus Concepts). Comparisons of proportions were done by using a chi-square test with Yates continuity correction.
Single-tailed tests were done to assess statistical significance. A result was considered statistically significant if the P value was c0.05.
RESULTS
The two groups of patients were very similar, as shown in Table 1 . Most patients had a very poor prognosis, as exemplified by the large proportion of patients with stage III and IV cancers on the one hand and recurrent disease on the other. All patients had involvement of the oropharyngeal cavity. Similarly, most of them underwent very extensive surgery in addition to neoadjuvant chemotherapy and radiation therapy. Total tumor excision and bilateral radical neck dissection with plastic reconstruction, including free flap reconstruction, corresponds to a prolonged surgical procedure with a time range of 12 to 24 h. Figure 1 shows the time delay from the time of surgery to the appearance of infectious complications.
Because of the small number of patients included in the study, we were not able to show a significant difference in the rate of postoperative wound infection, bacteremia, or bronchopneumonia (Table 2) . However, strict anaerobes were not isolated from patients who developed infections after clindamycin-amikacin prophylaxis, whereas strict anaerobes were associated with the wound infections of six patients in the sulbactam-ampicillin group. A similar proportion (42 and 44%, respectively) of the patients required antibiotic treatment within 20 days of surgery for a proven or suspected infection. This proportion corresponds to the overall failure rate of the two prophylactic regimens.
The pathogens isolated from wound infections are listed in Table 3 . Staphylococci were the most prevalent bacteria among the gram-positive organisms. Most gram-negative bacilli were typically of nosocomial origin and included multiresistant members of the family Enterobactenaceae and Pseudomonas aeruginosa. Table 3 shows that most pathogens that caused wound infections after clindamycin-amikacin prophylaxis were still susceptible to both antibiotics, whereas more than half of the microorganisms isolated after sulbactam-ampicillin prophylaxis were resistant to the combination. As A slightly more important number of patients from the clindamycin-amikacin group developed lung infiltrates that were mostly due to gram-negative rods. Among the six patients with bronchopneumonia from the ampicillin-sulbac- 
DISCUSSION
Many studies have supported the efficacies of several regimens such as those of clindamycin-aminoglycoside, various cephalosporins and broad-spectrum penicillins, and penicillin-p-lactamase inhibitor combinations (4-6, 9-12, 16-20, 25, 27, 28, 30, 31) . In our experience, clindamycinaminoglycoside is the most effective combination (11, 27) , supporting its use as the control treatment in the present study.
The pathogens expected to be found in wound and lower respiratory tract infections after extensive surgery for head and neck cancer are selected from the resident oropharyngeal flora (gram-positive aerobes and anaerobes, anaerobic gram-negative rods, S. aureus), the resident skin flora (S. epidernidis, other coagulase-negative staphylococci), and acquired opportunistic flora (multiresistant P. aeruginosa, other nonfermenters, methicillin-resistant staphylococci) (11, 27, 29) . The role of opportunistic pathogens has been well documented in our recent studies as well as others studies. They originate from the hospital environment, and in situations of high endemicity for organisms with multiresistant phenotypes, the bacteria may contribute dramatically to the failure rate observed with the currently recommended therapeutic regimens. This might have been the case in our institution with methicillin-resistant S. aureus.
After extensive surgery for head and neck cancer, the types of potentially preventable infectious complications include the following: local infections in 10 to 40% of patients (inducing flap necrosis, hemorrhage, rejection of foreign material), infections associated with ventilation in 5 to 20% of patients (tracheostomatitis, bronchopneumonia), and bacteremia in c5% of patients. Several factors have been associated with an increased risk for infection (19) , including pectoral flap and oropharyngeal resections (the risk was much higher than that after laryngectomy with or without radical neck dissection). The explanation for a higher risk of infection after oropharyngeal resection than after laryngectomy is due to the opening of the oropharyngeal cavities, which are heavily colonized with normal resident flora. In addition, the patients had systematic transient tracheostomies that allowed the colonization of their respiratory tracts and wounds. In the study of Johnson et al. (19) , preoperative tracheostomy and irradiation were not associated with an increased risk of infection. The duration of prophylaxis has been studied by Johnson et al. (19) ; the results indicated that there is no significant difference in the rate of infections between those who receive prophylaxis for 1 or 5 days. Similar results were reported at our institution (25) .
Despite the initial excellent effectiveness, the efficacy of antimicrobial prophylaxis in our institution has declined until now (Table 4) . Table 4 includes the results of six randomized studies (including the present one) that included 602 patients. This decreased efficacy is parall to the increased proportion of patients undergoing radical neck dissection. In addition, before 1987, only a unilateral radical dissection was performed during the same surgical procedure with tumor resection, whereas since that time, both sides are dissected simultaneously. The increased infection rate can be attributed to more aggressive adjuvant therapies (preoperative radiation therapy and chemotherapy) and the extent of surgery (large excision and reconstruction, including pedicled or free flaps), leading to a shift from a mean duration of surgery of about 8 h (early 1980s) to more than 12 h (late 1980s). However, other factors such as the increase in endemicity of methicillin-resistant S. aureus or other multiresistant nosocomial bacteria may have played a significant role as well.
Possible future strategies for antimicrobial prophylaxis for patients undergoing this type of surgery include the following: (i) more prolonged prophylaxis (the duration of surgery is now frequently longer than the half-life of the antimicrobial agents used, when the agents are given for 24 h), (ii) prolonged prophylaxis for a selected subgroup (when the duration of surgery is >12 h), (iii) potential for selective digestive decontamination to prevent bronchopneumonia, which has not been adequately prevented with the currently available regimens (1), (iv) use of topical antimicrobial agents to reduce the bacterial burden in heavily colonized patients (20, 22) , and (v) reassessment of preventive measures in the operating room (gloves and masks are ineffective after several hours of use, and multiple surgical sites are difficult to manage aseptically).
The two regimens tested in the study described here seemed to have similar efficacies in preventing postsurgical infections in patients undergoing surgery for head and neck cancer, although the small number of subjects in the study did not allow us to detect significant differences. It (11) , a similar trend was observed with 7 of 58 patients who received clindamycin-amikacin and 4 of 55 patients who received ticarcillin-clavulanic acid (P = 0.59; chi-square test with Yates correction). Pooling of the data from the two studies suggests that clindamycin-amikacin is slightly less effective than a ,B-lactam-,B-lactamase inhibitor combination (P = 0.08; one-tailed chi-square test) in preventing early bronchopneumonia. In microbiologically documented cases, most infections were due to gram-negative bacilli which were susceptible to amikacin in vitro. This result strongly suggests that the amount of bioactive amikacin in the bronchial secretions during the contaminating procedure was insufficient to prevent infection. Indeed, the penetration of aminoglycosides into bronchial secretions is very low in the absence of inflammation.
Further studies are needed to correlate pharmacokinetic and pharmacodynamic parameters with clinical efficacy in the prophylaxis of infections after extensive surgery in patients with head and neck cancer. excellent assistance. We thank N. Defresnes, M. Husson, and A. Vandermies for excellent technical assistance.
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